Cancer
Recent news:
Our researchers have received a new grant from the Biohub non-profit research organization, looking to advance the field of Spatiotemporal omics – the ability to sample biomolecules at different locations and times to watch disease processes unfold. Amy Herr and her UCSF partners Jennifer Rosenbluth and Amrita Basu will be studying integrated organoid systems for immunotherapy toxicity.
PhD alumnus Stanley Qi, now a professor at Stanford University, is interviewed about his work developing advanced gene-editing tools to treat life-threatening diseases and slow the onset of neurological aging.
Professor Derfogail Delcassian has been awarded $1 million in non-dilutive seed funding to accelerate the commercialization of her work on targeted molecular therapies for hard-to-treat cancers.
Pulse 2.0 interviewed MTM alumnus Sungwon Lim, founder of ImpriMed, a company that provides personalized medicine for pets with blood cancer diseases.
How isochoric preservation can protect food, organs — and even the planet. Professor Boris Rubinsky discusses the state of the art in cryogenics and preservation.
Congratulations to Professor Phillip Messersmith, a recipient of the 2023 Bakar Fellows Spark Award for his work on gel protection during tumor ablation. The award is designed to accelerate faculty-led research and produce tangible, positive societal impact through commercialization.
Undergraduate bioengineering student Alexandra Potter has been a long-term collaborator with Dr. CJ Yang of Harvard University on the effectiveness of lung cancer screening. Today she is first author on a paper published in the British Medical Journal, “Association of computed tomography screening with lung cancer stage shift and survival in the United States.” Potter is also CEO of the American Lung Cancer Screening Initiative.